Bispecific Antibodies in Multiple Myeloma and Practical Definitions of Lines of Therapy
Explore the transformative potential of bispecific antibodies in multiple myeloma, offering hope for improved patient outcomes and possible cures.
Addressing Therapeutic Gaps in Multiple Myeloma with Bispecific Antibody Therapies
Experts discuss the critical challenges in accessing innovative treatments for relapsed refractory multiple myeloma, emphasizing equity and education.
Challenges in the Management of Relapsed/Refractory Multiple Myeloma
Unmet Needs and Emerging Therapeutic Advances in Multiple Myeloma
Experts discuss the evolving role of bispecific antibodies in multiple myeloma, highlighting treatment advancements and strategies for optimal patient care.
